Tinzaparin for the treatment of foetal growth retardation: An open-labelled randomized clinical trial

Anette Tarp Hansen; Puk Sandager; Mette Ramsing; Olav B Petersen; Jannie D Salvig; Svend Juul; Niels Uldbjerg; Anne-Mette Hvas

doi:10.1016/j.thromres.2018.08.006

Tinzaparin for the treatment of foetal growth retardation: An open-labelled randomized clinical trial

Anette Tarp Hansen, Puk Sandager, Mette Ramsing, Olav B Petersen, Jannie D Salvig, Svend Juul, Niels Uldbjerg, Anne-Mette Hvas

4 Citations (Scopus)

Abstract

OBJECTIVE: Foetal growth retardation (FGR) is a leading cause of perinatal death and long-term harms at survivors. Placental infarction plays a role in FGR, yet, no trials have evaluated whether low molecular weight heparins increase birth weight in ongoing FGR pregnancies.METHODS: An open-labelled randomized trial in Denmark during 2011-2016, including singleton pregnant women with FGR (estimated foetal weight 

Original language	English
Journal	Thrombosis Research
Volume	170
Pages (from-to)	38-44
ISSN	0049-3848
DOIs	https://doi.org/10.1016/j.thromres.2018.08.006
Publication status	Published - Oct 2018
Externally published	Yes

Access to Document

10.1016/j.thromres.2018.08.006

Cite this

@article{2a9c214a3cd945cabc02169c571a7e21,

title = "Tinzaparin for the treatment of foetal growth retardation: An open-labelled randomized clinical trial",

abstract = "OBJECTIVE: Foetal growth retardation (FGR) is a leading cause of perinatal death and long-term harms at survivors. Placental infarction plays a role in FGR, yet, no trials have evaluated whether low molecular weight heparins increase birth weight in ongoing FGR pregnancies.METHODS: An open-labelled randomized trial in Denmark during 2011-2016, including singleton pregnant women with FGR (estimated foetal weight ",

author = "Hansen, {Anette Tarp} and Puk Sandager and Mette Ramsing and Petersen, {Olav B} and Salvig, {Jannie D} and Svend Juul and Niels Uldbjerg and Anne-Mette Hvas",

year = "2018",

month = oct,

doi = "10.1016/j.thromres.2018.08.006",

language = "English",

volume = "170",

pages = "38--44",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Pergamon Press",

}

TY - JOUR

T1 - Tinzaparin for the treatment of foetal growth retardation

T2 - An open-labelled randomized clinical trial

AU - Hansen, Anette Tarp

AU - Sandager, Puk

AU - Ramsing, Mette

AU - Petersen, Olav B

AU - Salvig, Jannie D

AU - Juul, Svend

AU - Uldbjerg, Niels

AU - Hvas, Anne-Mette

PY - 2018/10

Y1 - 2018/10

N2 - OBJECTIVE: Foetal growth retardation (FGR) is a leading cause of perinatal death and long-term harms at survivors. Placental infarction plays a role in FGR, yet, no trials have evaluated whether low molecular weight heparins increase birth weight in ongoing FGR pregnancies.METHODS: An open-labelled randomized trial in Denmark during 2011-2016, including singleton pregnant women with FGR (estimated foetal weight 

AB - OBJECTIVE: Foetal growth retardation (FGR) is a leading cause of perinatal death and long-term harms at survivors. Placental infarction plays a role in FGR, yet, no trials have evaluated whether low molecular weight heparins increase birth weight in ongoing FGR pregnancies.METHODS: An open-labelled randomized trial in Denmark during 2011-2016, including singleton pregnant women with FGR (estimated foetal weight 

U2 - 10.1016/j.thromres.2018.08.006

DO - 10.1016/j.thromres.2018.08.006

M3 - Journal article

C2 - 30114561

SN - 0049-3848

VL - 170

SP - 38

EP - 44

JO - Thrombosis Research

JF - Thrombosis Research

ER -